Inflammation and coagulation markers and kidney function decline: The Multi-Ethnic Study of Atherosclerosis (MESA)

American Journal of Kidney Diseases

Volumn 60, Issue 2, 2012, Pages 225-232

  Hiramoto, Jade S ^a   Katz, Ronit ^b   Peralta, Carmen A ^a   Ix, Joachim H ^c   Fried, Linda ^d,e,f   Cushman, Mary ^g   Siscovick, David ^b   Palmas, Walter ^h   Sarnak, Mark ⁱ   Shlipak, Michael G ^a,j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ TUFTS MEDICAL CENTER   (United States)

^j SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

coagulation markers; inflammation; Kidney function

Indexed keywords

BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CYSTATIN C; D DIMER; FIBRINOGEN; INTERLEUKIN 6;

ADULT; AGED; ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; DIABETES MELLITUS; ETHNICITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY;

AGED; ATHEROSCLEROSIS; BLOOD COAGULATION; C-REACTIVE PROTEIN; FACTOR VIII; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY; MALE; MIDDLE AGED;

EID: 84863985330     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.02.335     Document Type: Article

References (45)

1. P.M. Ridker, C.H. Hennekens, J.E. Buring, N. Rifai C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 12 2000 836 843
2. P.M. Ridker, N. Rifai, M.J. Stampfer, C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 15 2000 1767 1772
3. J.K. Pai, T. Pischon, J. Ma Inflammatory markers and the risk of coronary heart disease in men and women N Engl J Med 351 25 2004 2599 2610
4. T.J. Wang, P. Gona, M.G. Larson Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 25 2006 2631 2639
5. A. Herbelin, A.T. Nguyen, J. Zingraff, P. Urena, B. Descamps-Latscha Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha Kidney Int 37 1 1990 116 125
6. A. Herbelin, P. Urena, A.T. Nguyen, J. Zingraff, B. Descamps-Latscha Elevated circulating levels of interleukin-6 in patients with chronic renal failure Kidney Int 39 5 1991 954 960
7. M.J. Landray, D.C. Wheeler, G.Y. Lip Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the Chronic Renal Impairment in Birmingham (CRIB) Study Am J Kidney Dis 43 2 2004 244 253
8. M.G. Shlipak, L.F. Fried, C. Crump Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency Circulation 107 1 2003 87 92
9. K.D. Liu, D.V. Glidden, M.D. Eisner Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury Crit Care Med 35 12 2007 2755 2761
10. H.R. Jang, H. Rabb The innate immune response in ischemic acute kidney injury Clin Immunol 130 1 2009 41 50
11. G.R. Kinsey, L. Li, M.D. Okusa Inflammation in acute kidney injury Nephron Exp Nephrol 109 4 2008 e102 e107
12. E.M. Stuveling, H.L. Hillege, S.J. Bakker, R.O. Gans, P.E. De Jong, D. De Zeeuw C-Reactive protein is associated with renal function abnormalities in a non-diabetic population Kidney Int 63 2 2003 654 661
13. R. Pecoits-Filho, O. Heimburger, P. Barany Associations between circulating inflammatory markers and residual renal function in CRF patients Am J Kidney Dis 41 6 2003 1212 1218
14. L. Fried, C. Solomon, M. Shlipak Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals J Am Soc Nephrol 15 12 2004 3184 3191
15. C. Keller, R. Katz, M.J. Sarnak Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study Nephrol Dial Transplant 25 1 2010 119 124
16. M. Tonelli, F. Sacks, M. Pfeffer, G.S. Jhangri, G. Curhan Biomarkers of inflammation and progression of chronic kidney disease Kidney Int 68 1 2005 237 245
17. V. Menon, M.G. Shlipak, X. Wang Cystatin C as a risk factor for outcomes in chronic kidney disease Ann Intern Med 147 1 2007 19 27
18. D.E. Bild, D.A. Bluemke, G.L. Burke Multi-Ethnic Study of Atherosclerosis: objectives and design Am J Epidemiol 156 9 2002 871 881
19. C.A. Peralta, R. Katz, I. Deboer Racial and ethnic differences in kidney function decline among persons without chronic kidney disease J Am Soc Nephrol 22 7 2011 1327 1334
20. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
21. L.A. Stevens, J. Coresh, C.H. Schmid Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD Am J Kidney Dis 51 3 2008 395 406
22. D.E. Rifkin, M.G. Shlipak, R. Katz Rapid kidney function decline and mortality risk in older adults Arch Intern Med 168 20 2008 2212 2218
23. M.G. Shlipak, R. Katz, B. Kestenbaum Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C Am J Nephrol 30 3 2009 171 178
24. B.O. Eriksen, O.C. Ingebretsen The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age Kidney Int 69 2 2006 375 382
25. R.D. Lindeman, J. Tobin, N.W. Shock Longitudinal studies on the rate of decline in renal function with age J Am Geriatr Soc 33 4 1985 278 285
26. V.R. Dharnidharka, C. Kwon, G. Stevens Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis Am J Kidney Dis 40 2 2002 221 226
27. B.A. Perkins, R.G. Nelson, B.E. Ostrander Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study J Am Soc Nephrol 16 5 2005 1404 1412
28. L.D. Bash, T.P. Erlinger, J. Coresh, J. Marsh-Manzi, A.R. Folsom, B.C. Astor Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study Am J Kidney Dis 53 4 2009 596 605
29. A. Shankar, L. Sun, B.E. Klein Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study Kidney Int 80 11 2011 1231 1238
30. S.A. Jones, S. Horiuchi, N. Topley, N. Yamamoto, G.M. Fuller The soluble interleukin 6 receptor: mechanisms of production and implications in disease FASEB J 15 1 2001 43 58
31. D.A. Papanicolaou, R.L. Wilder, S.C. Manolagas, G.P. Chrousos The pathophysiologic roles of interleukin-6 in human disease Ann Intern Med 128 2 1998 127 137
32. D.V. Barreto, F.C. Barreto, S. Liabeuf Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease Kidney Int 77 6 2010 550 556
33. E.A. Bermudez, N. Rifai, J. Buring, J.E. Manson, P.M. Ridker Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women Arterioscleros Thrombos Vasc Biol 22 10 2002 1668 1673
34. B. Czarkowska-Paczek, I. Bartlomiejczyk, T. Gabrys, J. Przybylski, M. Nowak, L. Paczek Lack of relationship between interleukin-6 and CRP levels in healthy male athletes Immunol Lett 99 1 2005 136 140
35. L. Cristina, C. Benilde, C. Michela, F. Mirella, G. Giuliana, P. Gualtiero High plasma levels of factor VIII and risk of recurrence of venous thromboembolism Br J Haematol 124 4 2004 504 510
36. E. Oger, K. Lacut, P. Van Dreden High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly Haematologica 88 4 2003 465 469
37. P.A. Kyrle, E. Minar, M. Hirschl High plasma levels of factor VIII and the risk of recurrent venous thromboembolism N Engl J Med 343 7 2000 457 462
38. D. Stirling, W.A. Hannant, C.A. Ludlam Transcriptional activation of the factor VIII gene in liver cell lines by interleukin-6 Thromb Haemost 79 1 1998 74 78
39. R. Inagi Endoplasmic reticulum stress as a progression factor for kidney injury Curr Opin Pharmacol 10 2 2010 156 165
40. K. Yoh, K. Itoh, A. Enomoto Nrf2-deficient female mice develop lupus-like autoimmune nephritis Kidney Int 60 4 2001 1343 1353
41. Q. Ma, L. Battelli, A.F. Hubbs Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2 Am J Pathol 168 6 2006 1960 1974
42. A.T. Dinkova-Kostova, K.T. Liby, K.K. Stephenson Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress Proc Natl Acad Sci U S A 102 12 2005 4584 4589
43. M.S. Yates, M. Tauchi, F. Katsuoka Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes Mol Cancer Ther 6 1 2007 154 162
44. P.E. Pergola, P. Raskin, R.D. Toto Bardoxolone methyl and kidney function in CKD with type 2 diabetes N Engl J Med 365 4 2011 327 336
45. J. Coresh, E. Selvin, L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 17 2007 2038 2047